Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Even under conditions that threaten protein integrity, cell and organism survival depend on the ability to maintain the proteome. In stressed cells, BCL2-associated athanogene 3 (BAG3) is essential for protein homeostasis (proteostasis). Due to its multi-domain structure, its involved in a variety of processes that are critical to proteome maintenance. BAG3 promotes molecular chaperone activity, sequesters and concentrates of misfolded proteins, initiates autophagy processing, and balances transcription, translation and degradation.
BAG3 promotes chaperone activity
BAG3 is tightly integrated into the cell chaperone network, where the competition and cooperation between the complexes are essential for the formation of functional different chaperone complexes. BAG3 belongs to the family of co-chaperones having the BAG domain, which bind to the N-terminal ATPase domain of the 70 kDa heat shock protein (HSP70s). HSP70s are highly versatile chaperone proteins that recognize non-native proteins by transiently hydrophobic regions regulated by ATP. The BAG domain accessory partner acts as a nucleotide exchange factor (NEF) for HSP70 to facilitate client release and accelerate the chaperone cycle along with the J-domain co-chaperones, such as DNAJB6. Importantly, BAG3 exerts its HSP70 modulating activity in multicomponent chaperone complexes. Two IPV motifs mediate the binding of BAG3 to small heat shock proteins (sHSPs), such as HSPB6 and HSPB8. sHSP forms an oligomer assembly that isolates misfolded proteins in a state that allows for refolding or further processing. The interaction of sHSPs with BAG3 provides a means to couple their retention function to the folding activity of the multifunctional HSP70.
The most usual defense strategy against the toxic consequences of protein aggregation in cells is concentrate and isolate of misfolded proteins. The sHSPs play an important role in this sequestration, BAG3 regulate this process by interating with sHSPs, and BAG3 also promoting intracellular trafficking of misfolded proteins. Two RSQS motifs and a proline-rich PxxP domain contribute to the binding of the co-chaperone to the microtubule-motor kinesin; this involves 14-3-3 adaptor proteins and appears to be regulated by co-chaperone phosphorylation. Associated with kinesin movement allows BAG3 to induce HSP70 customers to retrograde along the microtubules to the perinuclear sites, so-called aggregates. The deposition of misfolded conformers in aggregates minimizes toxic interference to essential cellular processes and promotes efficient aggregate clearance by macroautophagy.
Fig. 1. BAG3 plays a critical role in the formation of multi-chaperone complexes and the stability of sHSPs. (Fang, et al.The Journal of Clinical Investigation. 2017).
BAG3 initiates an autophagy pathway
Autophagy is a pathway by which lysosomal hydrolases degrade excess or damaged cellular components. The cellular contents are engulfed by the double membrane, resulting in the formation of autophagosomes that eventually fuse with the lysosomal vesicles to achieve degradation of the contents. The first time autophagy was found in starved cells was a rather non-selective process. However, in recent years, an increasing number of selective autophagy pathways have been described which depend on the specific choice of cargo for autophagy delivery to lysosomes. Selection typically involves the initial labeling of the cargo with a degradation marker ubiquitin and subsequent recognition by an autophagy ubiquitin adaptor that provides linkage to an autophagosome precursor membrane. BAG3 and HSP70-associated ubiquitin ligase CHIP cooperate to induce this selectivity, ubiquitin-dependent autophagy pathway to treat chaperone clients. CHIP interacts with the C-terminus of HSP70, which covers the peptide binding site of the chaperone, and cooperates with ubiquitin conjugating enzymes (UBCs) in the ubiquitylation of HSP70-bound clients. In this case, the chaperone protein HSP70 becomes a degradation factor. In fact, CHIP-mediated ubiquitination has been shown to direct a wide range of HSP70 clients to different degradation pathways.
Cytosol clients are typically target to the proteasome, a protease complex specifically designed for the conversion of ubiquitinated proteins, and the plasma of the membrane is identical to its CHIP-mediated ubiquitination. However, when CHIP ubiquitylates clients that are presented by HSP70-BAG3-HSPB8 complexes, their autophagic degradation is favoured. The reason for this is not completely understood, but efficient recruitment of the autophagic ubiquitin adaptor SQSTM1 appears to be a decisive step, which promotes client loading onto phagophore membranes. Of note, other chaperone-associated ubiquitin ligases, such as the quality control ligase parkin (PRKN), may substitute for CHIP during the initiation of autophagy. Indeed, a recent study reveals a cooperation of BAG3 with parkin in the autophagic clearance of damaged mitochondria. It is also important to note that the pathway induced by BAG3 is distinct from chaperone-mediated autophagy (CMA). CMA does not depend on autophagosome formation, but instead involves a direct transfer of HSP70 clients across the lysosomal membrane. To emphasize this distinction, researchers coined the term chaperone-assisted selective autophagy (CASA) for the BAG3-induced pathway.
Fig. 2. BAG3 and Parkin translocate from cytosol to mitochondria upon depolarization. (Tahrir, et al. Journal of cellular physiology. 2017).
BAG3-mediated cytoskeleton maintenance is not restricted to striated muscle
In smooth muscle cells and non-muscle cells, filamin is associated with actin stress fibers, which form actin stress fibers when force is applied from cells or forces are generated within the cells during adhesion and migration. Stretching of smooth muscle cells and adhesion, spread and migration of lymphoblasts lead to the induction of BAG3, accompanied by an increase in autophagy renewal of filament proteins. In addition, BAG3 is critical for the movement and adhesion of a variety of cancer cells. Thus, CASA machine-mediated protein quality control appears to represent a broad and common mechanism for maintaining the cytoskeleton in muscle and non-muscle cells. Notably, HSPB8 and BAG3-dependent autophagy is also essential in dividing cells at stages when profound changes in cell tension occur, for instance during proper spindle orientation and the disassembly of the actin-based contractile ring during cytokinesis.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.